Corneal hysteresis as a biomarker of glaucoma: current insights

L Zimprich, J Diedrich, A Bleeker… - Clinical …, 2020 - Taylor & Francis
The diagnosis and management of glaucoma has long been dependent on making
decisions based on family history, optic nerve head evaluation, intraocular pressure, visual …

Clinical ocular biomechanics: where are we after 20 years of progress?

PT Yuhas, CJ Roberts - Current Eye Research, 2023 - Taylor & Francis
Purpose: Ocular biomechanics is an assessment of the response of the structures of the eye
to forces that may lead to disease development and progression, or influence the response …

The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma

R Meda, Q Wang, D Paoloni… - British Journal of …, 2017 - bjo.bmj.com
Aims To determine the influence of prostaglandin analogues (PGAs) on corneal
biomechanical properties in patients undergoing chronic treatment for primary open-angle …

Genome-wide association study of corneal biomechanical properties identifies over 200 loci providing insight into the genetic etiology of ocular diseases

MJ Simcoe, AP Khawaja, PG Hysi… - Human molecular …, 2020 - academic.oup.com
Corneal hysteresis and corneal resistance factor are parameters that reflect the dynamic
biomechanical properties of the cornea and have been shown to be biomarkers of corneal …

Changes in corneal biomechanical properties after long-term topical prostaglandin therapy

N Wu, Y Chen, X Yu, M Li, W Wen, X Sun - PloS one, 2016 - journals.plos.org
Objective To compare corneal biomechanical properties, measured by a newly developed
tonometer (Corneal Visualization Scheimpflug Technology, Corvis ST), in untreated primary …

Corneal hysteresis and glaucoma

L Liang, R Zhang, LY He - International ophthalmology, 2019 - Springer
Purpose To review and summarize the characteristics of corneal hysteresis (CH) and its
relationship with glaucoma. Methods A PubMed search was carried out using the terms …

A review of corneal biomechanics and scleral stiffness in topical prostaglandin analog therapy for glaucoma

SR Shen, GP Fleming, SG Jain, CJ Roberts - Current eye research, 2023 - Taylor & Francis
Purpose The mechanism of action underlying prostaglandin analog (PGA) therapy involves
changes in the expression of different metalloproteases to increase permeability of the …

A prospective longitudinal study to investigate corneal hysteresis as a risk factor of central visual field progression in glaucoma

A Kamalipour, S Moghimi, M Eslani, T Nishida… - American journal of …, 2022 - Elsevier
Purpose To evaluate the role of corneal hysteresis (CH) as a risk factor of central visual field
(VF) progression in a cohort of glaucoma suspect and glaucoma patients. Design …

A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension

A Katsanos, I Riva, B Bozkurt, G Holló… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction In the last 25 years, topical prostaglandin analogues (PGAs) have emerged to
become first line and first choice therapeutic options in the management of glaucoma and …

Corneal hysteresis: ready for prime time?

AA Jammal, FA Medeiros - Current opinion in ophthalmology, 2022 - journals.lww.com
Given the evidence supporting corneal hysteresis as an important risk factor for glaucoma
development and its progression, practitioners should consider measuring corneal …